Tag: TXA
Study results show TXA did not increase blood clots at 90-days follow-up
Editor's Note Recent findings from the TRACTION study in which patients undergoing higher-risk non-cardiac surgery received tranexamic acid (TXA) or a placebo, demonstrated that patients who received TXA, a generic drug that promotes blood clotting, needed significantly fewer blood transfusions and saw no increase in potentially life-threatening blood clots after…
Free Daily News
- Early career physicians cite higher burnout rate
- Study results show TXA did not increase blood clots at 90-days follow-up
- Ideas to balance AI safety and innovation
- Recommendations released for outpatient care following traumatic brain injury
- Study confirms safety and savings for same-day 360° lumbar fusion
- The biggest financial threats to ASCs in 2026
- Flu activity up but not above activity similar to past seasons
- Tips to apply AI-driven OR efficiencies
- A call for real-time captioning in the OR
- Ketamine fails in surgical recovery trial
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement